Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Dow
Medtronic
Merck
McKinsey

Last Updated: May 19, 2022

INTELENCE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Intelence, and what generic alternatives are available?

Intelence is a drug marketed by Janssen R And D and is included in one NDA.

The generic ingredient in INTELENCE is etravirine. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the etravirine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Intelence

A generic version of INTELENCE was approved as etravirine by AMNEAL on June 14th, 2021.

  Try it Free

Drug patent expirations by year for INTELENCE
Drug Prices for INTELENCE

See drug prices for INTELENCE

Recent Clinical Trials for INTELENCE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
IRCCS Eugenio MedeaPhase 2
University of Rome Tor VergataPhase 2
FundaciĆ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociĆ³n de la Salud y la CienciaPhase 1

See all INTELENCE clinical trials

US Patents and Regulatory Information for INTELENCE

INTELENCE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting INTELENCE

PEDIATRIC EXCLUSIVITY
Exclusivity Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen R And D INTELENCE etravirine TABLET;ORAL 022187-003 Mar 26, 2012 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Janssen R And D INTELENCE etravirine TABLET;ORAL 022187-001 Jan 18, 2008 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Janssen R And D INTELENCE etravirine TABLET;ORAL 022187-002 Dec 22, 2010 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for INTELENCE

International Patents for INTELENCE

See the table below for patents covering INTELENCE around the world.

Country Patent Number Title Estimated Expiration
Netherlands 300373 See Plans and Pricing
Poland 348145 See Plans and Pricing
Portugal 1129079 See Plans and Pricing
Czech Republic 20011533 See Plans and Pricing
African Intellectual Property Organization (OAPI) 11674 HIV Replication inhibiting pyrimidines. See Plans and Pricing
Taiwan 541305 See Plans and Pricing
Eurasian Patent Organization 200100536 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for INTELENCE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1002795 300373 Netherlands See Plans and Pricing 300373, 20191101, EXPIRES: 20230827
1002795 PA2008016,C1002795 Lithuania See Plans and Pricing PRODUCT NAME: ETRAVIRINUM; REGISTRATION NO/DATE: EU/1/08/468/001 20080828
1002795 CA 2009 00004 Denmark See Plans and Pricing
1002795 C01002795/01 Switzerland See Plans and Pricing PRODUCT NAME: ETRAVIRIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58483 13.05.2008
1002795 SZ 5/2009 Austria See Plans and Pricing PRODUCT NAME: ETRAVIRIN UND DESSEN ADDITIONSSALZE
1002795 337 Finland See Plans and Pricing
1002795 91528 Luxembourg See Plans and Pricing 91528, EXPIRES: 20230828
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
AstraZeneca
Dow
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.